Feature

EsoBiotec unlocking new possibilities for oncology and autoimmune disease by empowering cells in vivo

Closely held EsoBiotec is transforming cell therapy by engineering immune cells directly within a patient’s body, enabling the immune system to attack disease—potentially delivering cell therapy to patients in minutes...

July 15, 2025

Feature

Dotmatics empowering life-changing discoveries with next-gen therapeutic research solution

Closely held Dotmatics is transforming the therapeutic research and development landscape with Luma, a groundbreaking solution in multimodal data management with the potential to address long-standing scientific...

July 1, 2025

Feature

VeriSIM delivering predictive insights to advance and de-risk drug development

Closely held VeriSIM Life is leveraging multi-disciplinary quantitative methods to predict patient outcomes and accelerate the discovery, development, and commercialization of transformative therapies. The company aims...

June 24, 2025

Feature

Launchit Solutions enhancing patient outcomes through strategic partnerships and advanced medical programs

Launchit Solutions is leveraging breakthrough technology and clinically validated innovations to bring effective healthcare solutions to patients, with a focus on obesity management, support programs, life science...

June 17, 2025

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

EsoBiotec unlocking new possibilities for oncology and autoimmune disease by empowering cells in vivo

Dotmatics empowering life-changing discoveries with next-gen therapeutic research solution

VeriSIM delivering predictive insights to advance and de-risk drug development

Launchit Solutions enhancing patient outcomes through strategic partnerships and advanced medical programs

NEWS

Lake Street sees CMS’s proposed 2026 TULSA reimbursement as favorable

Cell One Partners’ video series: Dr. Stephen Chang reflects on 40 years of innovation in cell and gene therapy

Iovance appoints Corleen Roche as CFO

BiomX doses first patient in Phase 2b trial of BX004 in CF

Firefly’s FDA-cleared BNA platform underpins groundbreaking precision neuroscience study with Heidelberg University

Oncogene publishes remission for testicular cancer patient treated with MiNK’s iNKT cell therapy

Quince appoints Dr. Hassan Abolhassani to SAB

China’s NMPA approves Ascentage’s lisaftoclax for CLL/SLL

PharmaJet enters MOU for needle-free vaccine delivery in Egypt

Just a few of the companies we’ve highlighted along the way

Subscribe